2Puls LE,Dainhot T,Hunteo E,et al.The prognostic implication of ascites in advanced stage ovarian carcinoma[J].Gynecol Oncol,1996,61:109-111.
3Platsoucas CD.Human autologous tumor-specific T cells in malignant melanoma[J].Cancer & Metastasis Rev,2001,10(2):151-176.
4Akiyama M,Takahashi Y,Hirose M,et al.Riskfactors for retroperitoneal lymph node metastasis in ovarian cancer[J].Nippon Sanka Fujinka Gakkai Zasshi,1994,16:260.
5Simsek T,Simsek M,Pesterelli E,et al.The effect of platinum based combination chemotherapy on the lymph nodes in advanced2stage epithelial ovarian cancer:does it decrease the incidence of lymph node involvement[J].Obstet Gynecol,2002,22(6):666-668.
6Kuhn W,Rutke S,Spathe K,et al.Neoadjvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in Intenational Federation of Gynecology and Obstetrics stage Ⅲc ovarian carcinoma[J].Cancer,2007,92(10):2585-2591.
7Imachi M,Tsukamoto N,Shigematsu T,et al.Fine-needle aspiration cytology in patients with gynecologic malignancies[J].Gynecol Oncol,1992,46(3):309-312.
8Li L.The clinical application of monoclonal antibody of ovarian carcinoma[J].Chin J Obstet Gynecol,1985,12:205-257.
9任琼珍 胡建铭.卵巢癌腹水形成的相关因素分析.Suzhou Univvereity Iournal of Medical Science,2004,24(2):264-265.
10Adachi S,Noda T,Kiyozuka Y,et al.The importance of CA125 immunohistochemical staining in patients with ovarian cancer[J].Nippon Sanka Fujinka Gakkai Zasshi,2004,46(9):896-902.
